You are here

CAR-T

In first M&A strike, Paul Stoffels lays out 5-year plan to turn Galapagos around

Fierce Biotech

Thu, 06/23/22 - 10:54 am

Galapagos to enter cell therapy space with acquisition of CellPoint and AboundBio

Seeking Alpha

Tue, 06/21/22 - 11:50 pm

Bristol Myers Squibb takes its CAR-T patent case to US' top court in bid to revive $1.2B verdict against Gilead

Fierce Pharma

Thu, 06/16/22 - 10:48 pm

Bristol Myers Squibb

Gilead Sciences

Juno Therapeutics

Taking Charge—biotechs already approaching Novartis to partner on 'game changing' CAR-T platform

Fierce Biotech

Tue, 06/14/22 - 11:18 am

CRISPR Tx Drug Targeting CD70 Offers Early Hope for Difficult T Cell Lymphomas

BioSpace

Mon, 06/13/22 - 10:48 am

CRISPR Therapeutics

clinical trials

T-cell lymphoma

The hangover: Caribou's allogeneic CAR-T hit by durability doubts as half of patients relapse

Fierce Biotech

Fri, 06/10/22 - 10:55 am

Caribou Biosciences

allogenic CAR-T

non-Hodgkin's lymphoma

Precision hails phase 1/2 data as proof it could deliver the first approved off-the-shelf CAR-T

Fierce Biotech

Wed, 06/8/22 - 11:00 pm

Precision Biosciences

non-Hodgkin lymphoma

ASCO 2022 – Carvykti casts a long shadow

EP Vantage

Mon, 06/6/22 - 10:01 am

Multiple Myeloma

Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah

Yahoo/Zacks.com

Tue, 05/31/22 - 10:41 am

relapsed or refractory follicular lymphoma

ASCO: J&J, Legend reveal more CAR-T data and a look at Carvykti for earlier myeloma in a difficult population

Fierce Pharma

Fri, 05/27/22 - 10:33 am

Multiple Myeloma

Inceptor Bio generates $37m in funding round as it advances CAR-T platform into the clinic

Biopharma Reporter

Wed, 05/25/22 - 10:13 am

CAR T without the toxicity: Kelonia gets $50M for a new take on cell therapy

MedCity News

Sun, 05/22/22 - 09:06 pm

Kelonia Therapeutics

Inceptor Bio raises $37m from Series A to advance CAR-T lead program

Pharmaceutical Business Review

Fri, 05/20/22 - 10:32 am

Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death

Fierce Biotech

Fri, 05/20/22 - 10:22 am

Atara Biotherapeutics

clinical trials

BMS shows what’s NEX-T for CAR T, plus its strategy for next-gen cancer cell therapy

MedCity News

Wed, 05/4/22 - 10:35 am

Bristol Myers Squibb

WMIF panel: How cell and gene therapy can overcome limitations of CAR T

MedCity News

Tue, 05/3/22 - 10:35 am

World Medical Innovation Forum

Astellas, Tmunity, Underscore Rocky Terrain of CAR-T and Gene Therapies

BioSpace

Mon, 04/25/22 - 10:38 pm

myotubular myopathy

Study: Black patients underrepresented in pivotal CAR T-cell trials

RAPS.org

Thu, 04/21/22 - 11:20 pm

clinical trials

clinical trial diversity

Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T

BioSpace

Thu, 04/21/22 - 10:57 am

Kite’s Maryland CAR T-cell therapy site gets FDA go-ahead

Biopharma Reporter

Wed, 04/20/22 - 10:43 am

Gilead Sciences

drug manufacturing

Pages